|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 35/00 | |
| A61K 35/28 | |||
| A61K 35/768 | |||
| A61K 39/395 | |||
| A61K 35/30 | |||
| A61K 35/44 | |||
| A61K 38/19 |
| (11) | Number of the document | 3209382 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15852615.2 |
| Date of filing the European patent application | 2015-10-23 | |
| (97) | Date of publication of the European application | 2017-08-30 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/057234 |
| Date | 2015-10-23 |
| (87) | Number | WO 2016/065330 |
| Date | 2016-04-28 |
| (30) | Number | Date | Country code |
| 201462068557 P | 2014-10-24 | US | |
| 201462073907 P | 2014-10-31 | US |
| (72) |
SZALAY, Aladar, US
MINEV, Boris, US
|
| (73) |
Calidi Biotherapeutics, Inc.,
10210 Campus Point Drive Suite 150, San Diego, CA 92121,
US
|
| (54) | COMBINATION IMMUNOTHERAPY APPROACH FOR TREATMENT OF CANCER |
| COMBINATION IMMUNOTHERAPY APPROACH FOR TREATMENT OF CANCER |